Search results
Dozens take the 'Plunge for Patterson' to benefit research for rare skin disorder
KING5 Seattle· 7 days agoEpidermolysis Bullosa, "EB" for short, causes fragile and blistering skin. In his short life, McKenzie has benefited from the support of Jill and Eddie ...
Abeona shares tumble as FDA declines to approve skin disorder treatment
Reuters via AOL· 6 days agoThe health regulator sought certain additional data to satisfy requirements pertaining to chemistry,...
US FDA declines to approve Abeona’s skin disorder treatment
WHTC 1450 Holland· 6 days ago(Reuters) - Abeona Therapeutics said on Monday the U.S. health regulator had declined to approve its...
Abeona Therapeutics Shares Down 53% After FDA Complete Response Letter
Market Watch· 6 days agoBy Josh Beckerman Abeona Therapeutics shares fell 53%, to $3.45, after hours as its application for pz-cel received a Complete Response Letter from the U.S....
Friday's letters: Family has help in coping with rare disease
Greensboro News & Record· 2 days agoFirst of all, I want to thank Nancy McLaughlin for taking such a personal interest in my daughter...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoPITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its first quarter 2024 financial results on Monday, May 6, 2024
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
InvestorPlace· 5 days agoAbeona Therapeutics intends to provide the FDA with this information but can’t do so in a manner...
FDA rejects Abeona cell therapy, asks for more manufacturing data
BioPharma Dive via Yahoo Finance· 5 days agoAbeona on Monday said the FDA issued a so-called complete response letter for the therapy, known as...
Eddie Vedder at West Seattle polar plunge event to benefit skin disease research
AOL· 7 days agoPearl Jam lead vocalist Eddie Vedder was at Alki Beach on Sunday, participating in a polar plunge event to benefit research for a life-threatening skin disorder that affects children. Longtime ...
FDA requests more info for Abeona pz-cel market application (NASDAQ:ABEO)
Seeking Alpha· 6 days agoThe FDA has declined to approve Abeona Therapeutics' (ABEO) therapy pz-cel, stating that it needs...
